The US President Donald Trump plans to impose new tariffs on pharmaceuticals to boost domestic production, despite potential negative impacts on global markets and European exporters. Major pharmaceutical companies in Europe are concerned about the implications for jobs and medicine availability. Article complet (Euronews.com)